Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Gemox as First and Second Line Therapy in Unknown Primary Cancer

This study has been completed.
Information provided by (Responsible Party):
M.D. Anderson Cancer Center Identifier:
First received: July 13, 2006
Last updated: August 1, 2012
Last verified: August 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2010
  Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):